BRIDGENE BIOSCIENCES
BridGene Biosciences is a biotechnology company using cutting-edge chemoproteomic technology to discover and develop small molecules. It enables covalent small molecules to perform proteome-wide screening in live cells, which results in highly selective small molecules that drug traditionally undruggable targets.
BRIDGENE BIOSCIENCES
Social Links:
Industry:
Biotechnology Therapeutics
Founded:
2018-01-01
Address:
Sunnyvale, California, United States
Country:
United States
Website Url:
http://www.bridgenebio.com
Total Employee:
1+
Status:
Active
Contact:
.(408) 498-8127
Email Addresses:
[email protected]
Total Funding:
50.5 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Font Awesome Mobile Non Scaleable Content Nginx Amazon
Current Employees Featured
Founder
Investors List
Dyee Capital
Dyee Capital investment in Series B - BridGene Biosciences
Junson Capital
Junson Capital investment in Series B - BridGene Biosciences
Lapam Capital
Lapam Capital investment in Series B - BridGene Biosciences
Kaitai Capital
Kaitai Capital investment in Series A - BridGene Biosciences
Takeda Ventures
Takeda Ventures investment in Series A - BridGene Biosciences
WeDo Capital Management
WeDo Capital Management investment in Series A - BridGene Biosciences
Pangu Venture Capital
Pangu Venture Capital investment in Series A - BridGene Biosciences
Official Site Inspections
http://www.bridgenebio.com
- Host name: aec037177372cc6cd.awsglobalaccelerator.com
- IP address: 3.33.251.168
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
More informations about "BridGene Biosciences"
BridGene Biosciences - Crunchbase Company Profile & Funding
BridGene Biosciences is a biotechnology company using cutting-edge chemoproteomic technology to discover and develop small molecules.See details»
BridGene Biosciences, Inc. | LinkedIn
BridGene Biosciences, Inc. | 4,322 followers on LinkedIn. Small molecule discovery and development for undruggable targets | BridGene Biosciences is a biotechnology company focused on discovering ...See details»
BridGene Biosciences - PitchBook
BridGene Biosciences General Information Description. Operator of a biotechnology company intended to develop drugs for traditionally untreatable targets. The company combines technologies including covalent chemistry, …See details»
BridGene Biosciences, Inc. - San Jose, USA - bionity.com
Bridgenebio.com +14084988127. Share. Xing Linkedin Facebook X E-mail Loading... Bookmark. Bookmark list; Bookmark. Start-up. BridGene Biosciences, Inc. 75 Nicholson Ln 95134 San …See details»
BridGene Biosciences - Bridging Undruggable Targets and …
Jul 27, 2022 As a global organization, Junson Capital has investment professionals located in Hong Kong, New York, Palo Alto and Singapore. ... For more information, visit …See details»
BridGene Biosciences - Overview, News & Similar companies
Aug 28, 2023 BridGene Biosciences contact info: Phone number: (408) 498-8127 Website: www.bridgenebio.com What does BridGene Biosciences do? BridGene is a biotechnology …See details»
BridGene Biosciences - Craft
BridGene Biosciences is a biotechnology company developing a chemoproteomic platform. It combines covalent chemistry, chemical proteomics, and quantitative mass spectrometry …See details»
BridGene Biosciences - Company Profile - Tracxn
Mar 7, 2025 BridGene Biosciences - Developer of small-molecule drugs for the treatment of cancer. Raised a total funding of $50.5M over 2 rounds from 4 investors. Founded by Ping …See details»
BridGene Biosciences - Work in biotech
BridGene Biosciences is developing small molecules intended to target previously undruggable targets. Currently, about 90% of disease-associated diseases cannot be targeted by traditional …See details»
BridGene Biosciences Inc Overview - Salary.com
Discover essential details about BridGene Biosciences Inc, including address, contact, and journey of our company's evolution.See details»
BridGene Biosciences Announces $38.5 Million Series B Financing …
Jul 27, 2022 As a global organization, Junson Capital has investment professionals located in ... For more information, visit https://www.bridgenebio.com. Contact. Tiberend Strategic Advisors, …See details»
BridGene Biosciences, Inc. | Insights
Jan 10, 2024 Already A Biomedtracker Subscriber? You have access to the full company record through your subscription.See details»
BridGene Biosciences - Bridging Undruggable Targets and …
Aug 1, 2024 BridGene Eligible to Receive Up to $15 9 Million in Total Payments. SAN JOSE, Calif., Aug. 1, 2024 -- BridGene Biosciences, Inc., a leader in the discovery of small molecule …See details»
BridGene Biosciences Announces Strategic Collaboration with …
Feb 25, 2025 BridGene Eligible to Receive Upfront and Potential Milestone Payments of approximately $770 Million. SAN JOSE, Calif., Feb. 25, 2025 /PRNewswire/ -- BridGene …See details»
BridGene Biosciences - Bridging Undruggable Targets and …
SUNNYVALE, Calif., March 30, 2021 /PRNewswire/ -- BridGene Biosciences, Inc., a biotechnology company using cutting-edge technology to discover and develop small …See details»
BridGene Biosciences Announces $12 Million Series A ... - BioSpace
SUNNYVALE, Calif., May 5, 2021 /PRNewswire/ -- BridGene Biosciences, Inc. a biotechnology company using cutting-edge chemoproteomic technology to discover and develop small …See details»
BridGene Biosciences Announces Strategic Collaboration with …
Jan 3, 2024 BridGene Eligible to Receive More Than $700 Million in Potential Upfront and Milestone Payments. SAN JOSE, Calif., Jan. 3, 2024 /PRNewswire/ -- BridGene Biosciences, …See details»
Bridging Undruggable Targets and Precision Medicines - BridGene …
Jan 3, 2024 BridGene Biosciences Announces Strategic Collaboration with Takeda to Discover Small Molecule Drugs for Immunology and Neurology TargetsSee details»
BridGene Biosciences Announces Titles and Authors of Five …
SAN JOSE, Calif., Sept. 30, 2021 /PRNewswire/ -- BridGene Biosciences, Inc., a biotechnology company using a unique chemoproteomic technology to discover and develop small molecules …See details»
HiveBio selects 10 startups for first life sciences accelerator ...
2 days ago Here are the members of HiveBio's first cohort for its life sciences accelerator program geared towards underrepresented entrepreneurs.See details»